# Simultaneous Determination of the Five Constituents in Maiwei Dihuang Pills by the HPLC-DAD Method

Authors: Danchun Jia; Hong Cai; Yuan Ke
Journal: Evidence-Based Complementary and Alternative Medicine
 (2021)

---

## Abstract

Objective. The purpose of study is to establish an HPLC-DAD method for determination of the five constituents (deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol) in Maiwei Dihuang Pills. Methods. An Agilent ZORBAX SB-C18 chromatographic column was carried out to determine the five constituents of 50% methanol extract of Maiwei Dihuang Pills. Results. It was found the chromatographic peak resolution of each component in the study sample solution was 1.5 higher than that of other peaks and no peaks appeared in the blank control solution during the same time, suggesting specificity of HPLC-DAD was well established. The linearity test indicated that deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol were 11.6–72.3 μg/mL, 6.4–45.2 μg/mL, 35.2–237.6 μg/mL, 18.1–114.2 μg/mL, and 32.2–215.3 μg/mL, respectively, suggesting each component has a good linear relationship within its own range. Additionally, the precision of HPLC-DAD was confirmed by a precision test; the stability of the study sample solution was confirmed by a stability test; and good reproducibility of HPLC-DAD was proved by a reproducible test. The recovery rate test showed that relative standard deviation (RSD) of recovery rate in deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol was 100.26% (1.80%), 101.39% (1.74%), 101.19% (1.76%), 102.50% (1.65%), and 102.30% (1.58%), respectively. Conclusions. HPLC-DAD used to determine the five constituents in Maiwei Dihuang Pills, and it was easier and faster to operate, showing good condition in repeatability, precision, stability, and recovery, which is a great option for quality control.


---

## Body

## 1. Introduction

Maiwei Dihuang Pills, as a type of Chinese patent medicine, are composed ofOphiopogon japonicus, Schisandra chinensis, Rehmannia glutinosa, Cornus officinalis, yam, Poria cocos, Alisma orientalis, and peony bark, that is, Liuwei Dihuang Pills (another Chinese patent medicine) plus Ophiopogon japonicus and Schisandra chinensis. Maiwei Dihuang Pills were first recorded in a traditional Chinese medical book named “Shoushibaoyuan” by author Tingxian Gong and renamed “Maiwei Dihuang Pill” in the book “Medical Treasure” in the Qing Dynasty. Liuwei Dihuang Pills contribute to nourishing Yin and strengthening the kidney. The constituents of Ophiopogon japonicus and Schisandra chinensis are associated with relief of cough, fever, and annoyance. Maiwei Dihuang Pills are applied to the treatment of hot flashes and night sweats, dry throat, vertigo, and tinnitus, and soreness and weakness of the waists and knees. Among these eight constituents in Maiwei Dihuang Pills, the main medicinal compositions of Rehmannia glutinosa relate to polysaccharides, Rehmannia glutinosa glycosides (A, B, and D), diflavin, and catalpol [1]. The main effective constituents of Schisandra chinensis refer to lignans such as deoxyschizandrin, γ-schizandrin, and schizandrin [2]. Steroidal saponins (Ophiopogon saponin A, B, B′, C, C’D, and D), high isoflavones, and polysaccharides are the main effective components of Ophiopogon japonicus [3]. Iridoids, including monoglycoside, loganin, Cornus neoglycoside, and Swertia glycoside, are the major active component of Cornus officinalis [4]. Aromatic acids, mainly consisting of paeonol, and monoterpene glycosides mainly composed of paeoniflorin are associated with the main efficacious constituents of peony bark [5]. Polysaccharide is the major functional component of Poria cocos [6] and yam [7]. 24 acetylalisol A and 23 acetylalisol B are the main active constituents of Alisma orientalis [8]. At present, there is no content control standard for the constituents in Maiwei Dihuang Pills except for loganin and paeonol (Cornus officinalis and peony bark) in the Chinese Pharmacopoeia (2015 Edition) [9]. However, the composition of traditional Chinese medicine is complex, and it is not enough to control the quality of the whole preparation only by the two. High-performance liquid chromatography-diode array detector (HPLC-DAD) is an effective method for chemical analysis, which has been well established in a previous study [10, 11].In the present study, the HPLC-DAD method was used for the simultaneous determination of deoxyschizandrin,γ-schizandrin, loganin, paeoniflorin, and paeonol in the Maiwei Dihuang Pills, so as to improve and supplement its quality control methods.


## 2. Materials and Methods

### 2.1. Medicine Sample Selection

The control samples were listed as below, which were purchased from the China Institute for Food and Drug Control: deoxyschizandrin (batch No. 15020411, content 99.78%),γ-schizandrin (batch No. 15021710, content 99.78%), loganin (batch No. 111640–201005, content 99.24%), paeoniflorin (batch No. 110736–200610, content 99.82%), and paeonol (batch No. 110707–200506, content 100.00%). Eight study samples (Maiwei Dihuang Pills) in total were purchased from the Guangdong Health Pharmacy, meeting the standards of the Chinese Pharmacopoeia (2015 Edition). The details of Maiwei Dihuang Pills were as follows: (a) batch Nos. 14011562, 14011786, 14011560, 15013351, 14011566, and 15013347, specification: 9 g/pilla × 10 pills, Beijing Tongrentang Chinese Medicine Co., Ltd., CN; (b) batch No. 140701, specification 9 g/pill × 10 pills, Yaodu Pharmaceutical Co., Ltd., CN); and (c) batch No. 141102, specification 9 g/pill × 10 pills, Shanxi Tiansheng Pharmaceutical Co., Ltd., CN). Reagent materials are prepared as follows: methanol was selected as chromatographically pure; phosphoric acid and other reagents were considered as analytically pure; and Brand Wahaha purified water was prepared.


### 2.2. HPLC-DAD Analysis

The Agilent ZORBAX SB-C18 chromatographic column (4.5 mm × 145 mm, 5μm) was used to analyze and determine the 50% methanol extract of Maiwei Dihuang Pills. The mobile phase consisted of acetonitrile-water and 0.2% phosphoric acid, which were eluted according to Table 1. The specific parameters of HPLC-DAD were as follows: the volume flow of the mobile phase was 0.8 ml/min, the column temperature was 35°C, and the injection volume was 10 μL; the wavelength was set as 220 nm, 236 nm, 230 nm, and 274 nm; the retention time of deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol was kept 26.41 min, 24.88 min, 25.22 min, 27.34 min, and 45.53 min, respectively. The theoretical partition number shall be no less than 6000 for deoxyschizandrin and γ-schizandrin, no less than 26000 for loganin, no less than 26000 for paeoniflorin, and no less than 150000 for paeonol.Table 1
Gradient elution programs.
Time (min)A acetonitrile (%)B water (%)03978595107931489218991241585322080473664505545556040707525759010809010


### 2.3. Control Sample Solution Preparation

Each control sample was put into an individual volumetric flask and then fixed with absolute methanol to modify the concentrations of deoxyschizandrin (0.2 mg/mL),γ-schizandrin (0.13 mg/mL), loganin (0.34 mg/mL), paeoniflorin (0.62 mg/mL), and paeonol (0.68 mg/mL). Six volumes, 0.5, 1.5, 2.0, 2.5, 3.0, and 3.5 ml, of deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol were collected to prepare final concentrations by the mobile phase. The chromatogram of control samples is presented in Figure 1.Figure 1
HPLC chromatograms of the control sample solution (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; 4, paeoniflorin; and 5, paeonol).


### 2.4. Study Sample Solution Preparation

About 1.0 g of Maiwei Dihuang Pills was grinded and placed into a 50 ml round bottom flask supplemented with 25 mL of 50% methanol. The flask was sealed and stored at room temperature for 0.5 h, followed by ultrasonic treatment for 15 min by using an AS3120 ultrasonic instrument, then heated for 60 min, and supplemented with 50% methanol. After centrifugation at 10000 r/min, the supernatant was filtered through 0.22μm to obtain the final sample solution. The chromatogram of study samples (Cat. 14011560, Cat. 14011562, and Cat. 14011566) is presented in Figure 2.Figure 2
HPLC chromatograms of five constituents in the study sample solutions (Cat. 14011560, Cat. 14011562, and Cat. 14011566) (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; 4, paeoniflorin; and 5, paeonol).


### 2.5. Negative Control Sample Solution Preparation

The negative control solutions in the absence of paeoniflorin, loganin, or paeonol were prepared according to the prescription proportion and preparation process by the Chinese Pharmacopoeia (2015 Edition). Figures3 and 4 present the chromatograms in the absence of paeoniflorin, loganin, or paeonol.Figure 3
HPLC chromatograms of the blank control sample solution without paeoniflorin (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; and 5, paeonol).Figure 4
HPLC chromatograms of the blank control sample solution without loganin and paeonol (1, deoxyschizandrin; 2,γ-schizandrin; and 3, paeoniflorin).


## 2.1. Medicine Sample Selection

The control samples were listed as below, which were purchased from the China Institute for Food and Drug Control: deoxyschizandrin (batch No. 15020411, content 99.78%),γ-schizandrin (batch No. 15021710, content 99.78%), loganin (batch No. 111640–201005, content 99.24%), paeoniflorin (batch No. 110736–200610, content 99.82%), and paeonol (batch No. 110707–200506, content 100.00%). Eight study samples (Maiwei Dihuang Pills) in total were purchased from the Guangdong Health Pharmacy, meeting the standards of the Chinese Pharmacopoeia (2015 Edition). The details of Maiwei Dihuang Pills were as follows: (a) batch Nos. 14011562, 14011786, 14011560, 15013351, 14011566, and 15013347, specification: 9 g/pilla × 10 pills, Beijing Tongrentang Chinese Medicine Co., Ltd., CN; (b) batch No. 140701, specification 9 g/pill × 10 pills, Yaodu Pharmaceutical Co., Ltd., CN); and (c) batch No. 141102, specification 9 g/pill × 10 pills, Shanxi Tiansheng Pharmaceutical Co., Ltd., CN). Reagent materials are prepared as follows: methanol was selected as chromatographically pure; phosphoric acid and other reagents were considered as analytically pure; and Brand Wahaha purified water was prepared.


## 2.2. HPLC-DAD Analysis

The Agilent ZORBAX SB-C18 chromatographic column (4.5 mm × 145 mm, 5μm) was used to analyze and determine the 50% methanol extract of Maiwei Dihuang Pills. The mobile phase consisted of acetonitrile-water and 0.2% phosphoric acid, which were eluted according to Table 1. The specific parameters of HPLC-DAD were as follows: the volume flow of the mobile phase was 0.8 ml/min, the column temperature was 35°C, and the injection volume was 10 μL; the wavelength was set as 220 nm, 236 nm, 230 nm, and 274 nm; the retention time of deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol was kept 26.41 min, 24.88 min, 25.22 min, 27.34 min, and 45.53 min, respectively. The theoretical partition number shall be no less than 6000 for deoxyschizandrin and γ-schizandrin, no less than 26000 for loganin, no less than 26000 for paeoniflorin, and no less than 150000 for paeonol.Table 1
Gradient elution programs.
Time (min)A acetonitrile (%)B water (%)03978595107931489218991241585322080473664505545556040707525759010809010


## 2.3. Control Sample Solution Preparation

Each control sample was put into an individual volumetric flask and then fixed with absolute methanol to modify the concentrations of deoxyschizandrin (0.2 mg/mL),γ-schizandrin (0.13 mg/mL), loganin (0.34 mg/mL), paeoniflorin (0.62 mg/mL), and paeonol (0.68 mg/mL). Six volumes, 0.5, 1.5, 2.0, 2.5, 3.0, and 3.5 ml, of deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol were collected to prepare final concentrations by the mobile phase. The chromatogram of control samples is presented in Figure 1.Figure 1
HPLC chromatograms of the control sample solution (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; 4, paeoniflorin; and 5, paeonol).


## 2.4. Study Sample Solution Preparation

About 1.0 g of Maiwei Dihuang Pills was grinded and placed into a 50 ml round bottom flask supplemented with 25 mL of 50% methanol. The flask was sealed and stored at room temperature for 0.5 h, followed by ultrasonic treatment for 15 min by using an AS3120 ultrasonic instrument, then heated for 60 min, and supplemented with 50% methanol. After centrifugation at 10000 r/min, the supernatant was filtered through 0.22μm to obtain the final sample solution. The chromatogram of study samples (Cat. 14011560, Cat. 14011562, and Cat. 14011566) is presented in Figure 2.Figure 2
HPLC chromatograms of five constituents in the study sample solutions (Cat. 14011560, Cat. 14011562, and Cat. 14011566) (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; 4, paeoniflorin; and 5, paeonol).


## 2.5. Negative Control Sample Solution Preparation

The negative control solutions in the absence of paeoniflorin, loganin, or paeonol were prepared according to the prescription proportion and preparation process by the Chinese Pharmacopoeia (2015 Edition). Figures3 and 4 present the chromatograms in the absence of paeoniflorin, loganin, or paeonol.Figure 3
HPLC chromatograms of the blank control sample solution without paeoniflorin (1, deoxyschizandrin; 2,γ-schizandrin; 3, loganin; and 5, paeonol).Figure 4
HPLC chromatograms of the blank control sample solution without loganin and paeonol (1, deoxyschizandrin; 2,γ-schizandrin; and 3, paeoniflorin).


## 3. Results

### 3.1. Specificity

The solution of control samples, study samples, and negative control samples was detected under the 2-1 chromatographic analysis. The resolution of the chromatographic peak of each component, which was to be tested, in the study sample solution was 1.5 higher than that of other peaks. No peaks appeared in the negative control solution during the same time, suggesting the specificity of HPLC-DAD was well established.


### 3.2. Linearity

The control sample solution (10μL) was loaded and determined by using the Agilent260 HPLC-DAD (UV6000LP two-stage tube array detector, Thermo Fisher Scientific, CN). X indicates the concentrations of control samples, and Y indicates the peak area. Limit of detection (LOD) and limit of quantification (LOQ) were defined according to concentrations of control samples when the signal-to-noise ratios (S/N) were 3 and 10. The LOD was determined experimentally and taken as the concentration producing a detector signal that could be clearly distinguished from the baseline noise (3 times the baseline noise). The LOQ was taken as the concentration that produced a detector signal ten times the baseline noise. The chromatograph was recorded and detailed in Table 2, indicating each component has a good linear relationship within its own range.Table 2
Linearity of the five constituents.
ConstituentRegression equationrLinear range (μg/mL)LOD (μg/mL)LOQ (μg/mL)Deoxyschizandriny = 16.774x + 22.5360.99811.6–72.30.070.18γ-Schizandriny = 34.115x + 43.5750.9996.4–45.20.050.12Loganiny = 11.245x + 22.6790.99435.2–237.60.100.31Paeonifloriny = 25.414x + 7.5870.99718.1–114.20.090.25Paeonoly = 44.574x + 22.3640.99632.2–215.30.040.11


### 3.3. Precision

Evaluation was based on relative standard deviation (RSD%). After 5 times of detection in the control sample solution, the RSD of the peak areas of the five constituents was found to be 0.95%, 1.18%, 0.96%, 0.76%, and 0.73%, which were below 1.3%. The data confirmed the precision of HPLC-DAD.


### 3.4. Stability

According to 2-1 chromatographic analysis, the study sample solution (Batch No. 14011786) was tested at room temperature in 0, 2, 4, 6, 8, and 10 h, respectively. The RSD of the peak areas of the five constituents was 1.15%, 0.79%, 0.90%, 0.81%, and 0.64%, respectively, which were less than 1.5%, indicating the stability of the study sample solution after 24 h at room temperature.


### 3.5. Reproducible

Five study sample solutions (Batch No. 14011786) were prepared and detected by chromatography. It was found the RSD of peak areas of the five constituents was 0.78%, 0.81%, 0.99%, 0.75%, and 0.64%, respectively, and all RSDs were less than 1.8%, revealing HPLC-DAD has good reproducibility.


### 3.6. Recovery Rate Test

Nine study samples in total with the same amount (Batch No. 14011786) were prepared and divided into 3 groups. 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of deoxyschizandrin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution ofγ-schizandrin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of loganin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of paeoniflorin, and 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of paeonol were added into the 3 groups of study samples, respectively. The recovery rate of the study sample solution was tested and recorded in Table 3.Table 3
Recovery of the five constituents.
ConstituentsSample quantity (g)Original quantity (g)Addition quantity (g)Measured quantity (g)Recovery rate (%)Average recovery rate (%)RSD (%)Deoxyschizandrin3.00011.29462.38413.6805100.07100.261.83.00081.29642.3843.7024100.923.0011.29612.3843.7027100.953.00071.29571.1922.5048101.433.00061.29631.1922.5364104.0331.29611.1922.5211102.773.00041.29650.5691.840595.613.00021.29630.5691.841295.763.00031.29650.5691.8701100.81γ-Schizandrin3.00042.74213.8026.6263102.16101.391.743.00052.74223.8026.5674100.613.00012.74383.8026.6057101.573.00022.74291.9014.6874102.293.00042.74261.9014.632599.423.00032.74271.9014.7056103.263.00042.74290.95053.7138102.153.00022.74260.95053.684599.13.00012.74310.95053.7122101.96Loganin3.00051.13042.894.0675101.63101.191.763.00061.13362.893.99498.983.00071.13152.894.0426100.733.00081.13121.4452.5842100.553.00071.13261.4452.5839100.443.00061.13351.4452.5876100.633.00061.13410.72251.8744102.463.00041.13190.72251.8726102.523.00051.13270.72251.8753102.78Paeoniflorin3.00091.49521.8463.3752101.84102.51.653.00061.49371.8463.3748101.93.00041.49591.8463.3751101.83.0011.49280.9232.4253101.033.00071.49750.9232.4249100.483.00041.49360.9232.4254100.953.00031.49440.46151.978104.793.00021.49450.46151.9785104.873.00021.49510.46151.9788104.81Paeonol3.00043.51034.2187.7436100.36102.31.583.00053.51064.2187.7429100.343.00063.51074.2187.7433100.353.00063.51092.1095.6756102.643.00073.51062.1095.6748102.623.00083.51042.1095.6743102.63.0013.51031.05454.6058103.893.00093.51051.05454.60721043.00073.51081.05454.6066103.92


### 3.7. Sample Content Test

An appropriate amount of study samples from different batches (Nos. 14011562, 14011786, 14011560, 15013351, 14011566, and 15013347) was prepared for the test solution. An external standard method was applied to calculate the content of constituents, and the results are listed in Table4.Table 4
Final contents of the five constituents.
Batch no.Deoxyschizandrin (mg/g)γ-Schizandrin (mg/g)Loganin (mg/g)Paeoniflorin (mg/g)Paeonol (mg/g)140115620.29480.12040.49810.37521.1705140115600.30040.12060.70540.40261.1742150133510.29710.1210.54310.53480.9984140115660.29280.12430.54260.46241.1234150133470.30050.12070.67150.48751.1457


## 3.1. Specificity

The solution of control samples, study samples, and negative control samples was detected under the 2-1 chromatographic analysis. The resolution of the chromatographic peak of each component, which was to be tested, in the study sample solution was 1.5 higher than that of other peaks. No peaks appeared in the negative control solution during the same time, suggesting the specificity of HPLC-DAD was well established.


## 3.2. Linearity

The control sample solution (10μL) was loaded and determined by using the Agilent260 HPLC-DAD (UV6000LP two-stage tube array detector, Thermo Fisher Scientific, CN). X indicates the concentrations of control samples, and Y indicates the peak area. Limit of detection (LOD) and limit of quantification (LOQ) were defined according to concentrations of control samples when the signal-to-noise ratios (S/N) were 3 and 10. The LOD was determined experimentally and taken as the concentration producing a detector signal that could be clearly distinguished from the baseline noise (3 times the baseline noise). The LOQ was taken as the concentration that produced a detector signal ten times the baseline noise. The chromatograph was recorded and detailed in Table 2, indicating each component has a good linear relationship within its own range.Table 2
Linearity of the five constituents.
ConstituentRegression equationrLinear range (μg/mL)LOD (μg/mL)LOQ (μg/mL)Deoxyschizandriny = 16.774x + 22.5360.99811.6–72.30.070.18γ-Schizandriny = 34.115x + 43.5750.9996.4–45.20.050.12Loganiny = 11.245x + 22.6790.99435.2–237.60.100.31Paeonifloriny = 25.414x + 7.5870.99718.1–114.20.090.25Paeonoly = 44.574x + 22.3640.99632.2–215.30.040.11


## 3.3. Precision

Evaluation was based on relative standard deviation (RSD%). After 5 times of detection in the control sample solution, the RSD of the peak areas of the five constituents was found to be 0.95%, 1.18%, 0.96%, 0.76%, and 0.73%, which were below 1.3%. The data confirmed the precision of HPLC-DAD.


## 3.4. Stability

According to 2-1 chromatographic analysis, the study sample solution (Batch No. 14011786) was tested at room temperature in 0, 2, 4, 6, 8, and 10 h, respectively. The RSD of the peak areas of the five constituents was 1.15%, 0.79%, 0.90%, 0.81%, and 0.64%, respectively, which were less than 1.5%, indicating the stability of the study sample solution after 24 h at room temperature.


## 3.5. Reproducible

Five study sample solutions (Batch No. 14011786) were prepared and detected by chromatography. It was found the RSD of peak areas of the five constituents was 0.78%, 0.81%, 0.99%, 0.75%, and 0.64%, respectively, and all RSDs were less than 1.8%, revealing HPLC-DAD has good reproducibility.


## 3.6. Recovery Rate Test

Nine study samples in total with the same amount (Batch No. 14011786) were prepared and divided into 3 groups. 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of deoxyschizandrin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution ofγ-schizandrin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of loganin, 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of paeoniflorin, and 4.0 ml, 2.0 ml, and 1.0 ml of the initial solution of paeonol were added into the 3 groups of study samples, respectively. The recovery rate of the study sample solution was tested and recorded in Table 3.Table 3
Recovery of the five constituents.
ConstituentsSample quantity (g)Original quantity (g)Addition quantity (g)Measured quantity (g)Recovery rate (%)Average recovery rate (%)RSD (%)Deoxyschizandrin3.00011.29462.38413.6805100.07100.261.83.00081.29642.3843.7024100.923.0011.29612.3843.7027100.953.00071.29571.1922.5048101.433.00061.29631.1922.5364104.0331.29611.1922.5211102.773.00041.29650.5691.840595.613.00021.29630.5691.841295.763.00031.29650.5691.8701100.81γ-Schizandrin3.00042.74213.8026.6263102.16101.391.743.00052.74223.8026.5674100.613.00012.74383.8026.6057101.573.00022.74291.9014.6874102.293.00042.74261.9014.632599.423.00032.74271.9014.7056103.263.00042.74290.95053.7138102.153.00022.74260.95053.684599.13.00012.74310.95053.7122101.96Loganin3.00051.13042.894.0675101.63101.191.763.00061.13362.893.99498.983.00071.13152.894.0426100.733.00081.13121.4452.5842100.553.00071.13261.4452.5839100.443.00061.13351.4452.5876100.633.00061.13410.72251.8744102.463.00041.13190.72251.8726102.523.00051.13270.72251.8753102.78Paeoniflorin3.00091.49521.8463.3752101.84102.51.653.00061.49371.8463.3748101.93.00041.49591.8463.3751101.83.0011.49280.9232.4253101.033.00071.49750.9232.4249100.483.00041.49360.9232.4254100.953.00031.49440.46151.978104.793.00021.49450.46151.9785104.873.00021.49510.46151.9788104.81Paeonol3.00043.51034.2187.7436100.36102.31.583.00053.51064.2187.7429100.343.00063.51074.2187.7433100.353.00063.51092.1095.6756102.643.00073.51062.1095.6748102.623.00083.51042.1095.6743102.63.0013.51031.05454.6058103.893.00093.51051.05454.60721043.00073.51081.05454.6066103.92


## 3.7. Sample Content Test

An appropriate amount of study samples from different batches (Nos. 14011562, 14011786, 14011560, 15013351, 14011566, and 15013347) was prepared for the test solution. An external standard method was applied to calculate the content of constituents, and the results are listed in Table4.Table 4
Final contents of the five constituents.
Batch no.Deoxyschizandrin (mg/g)γ-Schizandrin (mg/g)Loganin (mg/g)Paeoniflorin (mg/g)Paeonol (mg/g)140115620.29480.12040.49810.37521.1705140115600.30040.12060.70540.40261.1742150133510.29710.1210.54310.53480.9984140115660.29280.12430.54260.46241.1234150133470.30050.12070.67150.48751.1457


## 4. Discussion

Maiwei Dihuang Pills consist of eight constituents, includingOphiopogon japonicus, Schisandra chinensis, Rehmannia glutinosa, Cornus officinalis, yam, Poria cocos, Alisma orientalis, and peony bark. The function of Maiwei Dihuang Pills is mainly related to the diseases such as kidney deficiency, asthma, cough, fatigue, and night sweats. The HPLC-DAD method is often used to determine the active constituents of traditional Chinese medicine preparations in drug analysis. The component content of Chinese patent medicine preparation is associated with the safety and efficacy of medicine. Therefore, the study aimed to investigate the main five constituents, involving deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol, of Maiwei Dihuang pills, to ensure the quality control.Huang et al. [12] pointed out the accuracy and precision of the HPLC-DAD-ESI-MS method has been proven in the detection of elderberry. In this study, it was found the specificity of HPLC-DAD was confirmed according to the specificity test, revealing the chromatographic peak resolution of each component, which was to be tested, in the study sample solution was 1.5 higher than that of other peaks, and no peaks appeared in the negative control solution during the same time. In the linear relationship investigation, the linear range of deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol was 11.6–72.3 μg/mL, 6.4–45.2 μg/mL, 35.2–237.6 μg/mL, 18.1–114.2 μg/mL, and 32.2–215.3 μg/mL, respectively, indicating the good condition of the linear relationship. The remaining detections, including the reproducible test, stability test, and precision test, demonstrated the RSD of the peak area in the five constituents was lower than 1.8%. These outcomes manifested the HPLC-DAD method has good precision, stability, and reproducibility. The assessment of peak area RSD is an essential part in terms of accuracy, precision, and selectivity in the material analysis, which was confirmed in a previous study [13]. When selecting the wavelength for detection, the DAD observed the five constituents (deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol) were fully absorbed at the wavelength of 220 nm, 220 nm, 236 nm, 230 nm, and 274 nm, respectively, as well as the stability of chromatogram baseline. During the preparation of the study sample solution, it was found the study sample could be fully extracted by ultrasound for 15 min. In addition, we found that it is not appropriate to choose methanol-water (0.2% phosphoric acid) for elution of the study sample extracting solution, which was caused by abnormal chromatographic peak forms, imperfect resolution of lignans, and long-time detection. But, when we change the methanol-water to acetonitrile-water (0.2% phosphoric acid) as the mobile phase, it was observed the chromatographic peak forms of each component was significantly improved and overall analysis time was shortened and also chromatographic peaks of each component and adjacent chromatographic peaks reached the baseline with good peak form as well. The better outcomes might be associated with the complexity and diversity of chemical constituents in Maiwei Dihuang Pills. Shedania et al. [14] indicated acetonitrile and acetonitrile-water mixtures as mobile phases were related to better separation in chiral sulfoxides. The lignans, such as deoxyschizandrin and γ-schizandrin in Schisandra chinensis, contributed to protection of the liver and central nervous system and antioxidation [15]. Loganin is related to alleviating inflammation and relieving cough [16]. Paeoniflorin is good for pain relief and anti-inflammation [17]. Paeonol is beneficial in diminishing inflammation, relieving fever, and easing pain [18]. According to the recovery rate test in this study, the RSD of recovery rate, which was revealed in deoxyschizandrin, γ-schizandrin, loganin, paeoniflorin, and paeonol, was 100.26% (1.80%), 101.39% (1.74%), 101.19% (1.76%), 102.50% (1.65%), and 102.30% (1.58%), respectively, indicating the HPLC-DAD method is associated with good recovery rate. After the sample content test, although the same treatment was applied to the study sample solution, some difference was revealed in the contents of the five constituents from different batches, which might be motivated by original medicinal materials. Furthermore, small difference in preparation, transportation, and storage may also affect the content of each component of the final product. These data we found were similar to those of previous research, which has indicated the HPLC-DAD is an effective quantitative analytical method [19].In general, during the production of traditional Chinese medicine preparations, the quality of original medicinal materials should be strictly controlled according to the standards, to ensure the safety and efficacy of finished products. In conclusion, HPLC-DAD was carried out to determine the five constituents in Maiwei Dihuang Pills at the same time, which was proved as a simple but effective method with fine stability, precision, and reproducibility. Recent evidence shows that, in addition to deoxyschizandrin andγ-schizandrin, the main active ingredients of Schisandra chinensis also include schizandrin, aomisin, pseudo-r-schizandrin, and schizantherin A. Simultaneous determination of more constituents in Maiwei Dihuang Pills by the HPLC-DAD method is required in the future.



---

*Source: 2536558-2021-09-03.xml*